# Prevention of Delirium in Inpatients Utilizing Melatonin

> **NCT02654314** · PHASE3 · TERMINATED · sponsor: **Yale University** · enrollment: 277 (actual)

## Conditions studied

- Delirium

## Interventions

- **DRUG:** Melatonin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02654314
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-07
- **Primary completion:** 2017-11-03
- **Final completion:** 2017-11-03
- **Target enrollment:** 277 (ACTUAL)
- **Why stopped:** Lack of resources to complete the study. Descriptive statistics for the outcome measures collected are provided.
- **Last updated:** 2022-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02654314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02654314, "Prevention of Delirium in Inpatients Utilizing Melatonin". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02654314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*